Hopkins MM - Search Results

1

Supporting the vital role of boundary-spanning physician researchers in the advancement of medical innovation.

Hopkins MM, Ibanez F, Skingle M. Hopkins MM, et al. Future Healthc J. 2021 Jul;8(2):e210-e217. doi: 10.7861/fhj.2021-0091. Future Healthc J. 2021. PMID: 34286187 Free PMC article.

2

Appraising research policy instrument mixes: a multicriteria mapping study in six European countries of diagnostic innovation to manage antimicrobial resistance.

Coburn J, Bone F, Hopkins MM, Stirling A, Mestre-Ferrandiz J, Arapostathis S, Llewelyn MJ. Coburn J, et al. Among authors: hopkins mm. Res Policy. 2021 May;50(4):104140. doi: 10.1016/j.respol.2020.104140. Res Policy. 2021. PMID: 33941992 Free PMC article.

3

Challenges for research uptake for health policymaking and practice in low- and middle-income countries: a scoping review.

Semahegn A, Manyazewal T, Hanlon C, Getachew E, Fekadu B, Assefa E, Kassa M, Hopkins M, Woldehanna T, Davey G, Fekadu A. Semahegn A, et al. Health Res Policy Syst. 2023 Dec 6;21(1):131. doi: 10.1186/s12961-023-01084-5. Health Res Policy Syst. 2023. PMID: 38057873 Free PMC article. Review.

4

A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance.

Mott DJ, Hampson G, Llewelyn MJ, Mestre-Ferrandiz J, Hopkins MM. Mott DJ, et al. Among authors: hopkins mm. Appl Health Econ Health Policy. 2020 Feb;18(1):69-79. doi: 10.1007/s40258-019-00516-0. Appl Health Econ Health Policy. 2020. PMID: 31541361 Free PMC article.

5

Authors' Reply to Hays: "A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance".

Mott DJ, Hampson G, Llewelyn MJ, Mestre-Ferrandiz J, Hopkins MM. Mott DJ, et al. Among authors: hopkins mm. Appl Health Econ Health Policy. 2020 Jun;18(3):459-460. doi: 10.1007/s40258-020-00573-w. Appl Health Econ Health Policy. 2020. PMID: 32201931 No abstract available.

6

Putting pharmacogenetics into practice.

Hopkins MM, Ibarreta D, Gaisser S, Enzing CM, Ryan J, Martin PA, Lewis G, Detmar S, van den Akker-van Marle ME, Hedgecoe AM, Nightingale P, Dreiling M, Hartig KJ, Vullings W, Forde T. Hopkins MM, et al. Nat Biotechnol. 2006 Apr;24(4):403-10. doi: 10.1038/nbt0406-403. Nat Biotechnol. 2006. PMID: 16601719

7

Biomarker patents for diagnostics: problem or solution?

Hopkins MM, Hogarth S. Hopkins MM, et al. Nat Biotechnol. 2012 Jun 7;30(6):498-500. doi: 10.1038/nbt.2257. Nat Biotechnol. 2012. PMID: 22678384 No abstract available.

8

Reply to C.D. Richter.

Liddicoat J, Liddell K, McCarthy AH, Hogarth S, Aboy M, Nicol D, Patton S, Hopkins MM. Liddicoat J, et al. Among authors: hopkins mm. Eur J Hum Genet. 2020 May;28(5):537-538. doi: 10.1038/s41431-020-0588-x. Epub 2020 Feb 17. Eur J Hum Genet. 2020. PMID: 32066933 Free PMC article. No abstract available.

9

The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies.

Woelderink A, Ibarreta D, Hopkins MM, Rodriguez-Cerezo E. Woelderink A, et al. Among authors: hopkins mm. Pharmacogenomics J. 2006 Jan-Feb;6(1):3-7. doi: 10.1038/sj.tpj.6500341. Pharmacogenomics J. 2006. PMID: 16314885 No abstract available.

10

Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe.

van den Akker-van Marle ME, Gurwitz D, Detmar SB, Enzing CM, Hopkins MM, Gutierrez de Mesa E, Ibarreta D. van den Akker-van Marle ME, et al. Among authors: hopkins mm. Pharmacogenomics. 2006 Jul;7(5):783-92. doi: 10.2217/14622416.7.5.783. Pharmacogenomics. 2006. PMID: 16886902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters